BioCT appoints David Scheer as Co-Chair of the Board of Directors, welcomes new director

NEW HAVEN, Conn., October 12, 2023--BioCT is delighted to announce the appointment of David Scheer as Co-Chair of its Board of Directors. With a distinguished career in the life sciences industry and extensive experience in building successful companies, David brings invaluable expertise to his new leadership role within BioCT.

Related Keywords

New Haven ,Connecticut ,United States ,Caitlin Truesdale ,Matt Storeygard ,Jodie Gillon ,David Scheer ,Holiday Party ,Grossman Medical School ,Achillion Pharmaceuticals ,Scheer Company Inc ,Refactor Health ,David Scheer As Co ,Rutgers Global Health Institute ,Board Of Achillion Pharmaceuticals Inc ,Health Care Investing Team ,Board Of The Connecticut Bioscience Innovation Fund ,Adela Inc ,Wolverine Foundation ,Life Sciences ,Committee Of The Soderstrom Scholars Fund ,Oak Investment Partners ,Executive Committee ,Soderstrom Scholars Fund ,Connecticut Bioscience Innovation ,Medical School ,Senior Managing Director ,Connecticut Innovations ,Annual Holiday Party December ,Legislative Breakfast January ,Board Of Directors ,Co Chair ,David ,Successful Companies ,Nvaluable Expertise ,